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Abstract The DNA fragment encoding CrylAb domain I1-III 
(45.3 kDa) was cloned and expressed. Domain l l - I l I  is expressed 
in low yields. In vitro binding analysis to Manduca sexta and 
Trichoplusia ni larval midgut tissue sections demonstrated that 
domain II-I I I fragment bound along the microvilli of the midgut 
epithelium, indicating that this fragment retains binding func- 
tionality in the absence of domain I. Binding of domain II-I I I to 
the midgut brush border membrane proteins from I". ni larvae 
indicated that CrylAb toxin and domain II-I I I bind to the same 
150 kDa protein. In contrast, in M. sexta membranes, CrylAb 
toxin binds to 200 and 120 kDa proteins, and domain II-I I I only 
binds to the 200 kDa protein. Finally, binding assays with 
isolated brush border membrane vesicles showed that the 
interaction of domain II-III with the membrane vesicles is highly 
reversible, supporting the proposition that the integration of 
domain I into the membrane could participate in the irreversible 
binding of the toxin. These studies confirm that this part of the 
toxin is involved in binding interactions and could be separated as 
a discrete fragment that conserves at least part of its 
functionality. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Bacillus thuringiensis a Gram-positive, spore-forming bac- 
terium which produces parasporal crystals during sporulation. 
Crystals are predominantly comprised of one or more pro- 
teins, called 8-endotoxins or Cry proteins, known to possess 
insecticidal activity when ingested by certain insects. The 
genes for a number of Cry proteins have been cloned and 
sequenced. They have been classified into 19 different homol- 
ogy groups based on sequence similarity [1]. Each Cry protein 
is highly specific against its target. 
A generally accepted model for the mode of action of Cry is 
that it is a multistage process. First, the crystals ingested by a 
susceptible larva dissolve in the alkaline environment of the 
gut, releasing soluble proteins. The inactive protoxins are 
cleaved by proteases yielding 60-70 kDa protease resistant, 
active toxin fragments [2]. The activated toxin binds to recep- 
tors located on the apical microvillus membrane of epithelial 
midgut cells [3 5]. After receptor binding, a change in the 
toxin conformation is thought to occur, allowing toxin inser- 
tion into the membrane. Oligomerization of the toxin follows, 
and this oligomer then forms a pore that leads to osmotic cell 
lysis [6-9]. 
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The three-dimensional structures of the Cry3A and CrylAa 
toxins (which share 33% sequence identity) have been solved 
[7,10]. The similarity in their structures is extensive. A toxin 
molecule is comprised of three domains connected by single 
linkers. Domain I, extending from the N-terminus, is a seven 
c~-helix bundle, with helix c~-5 in the center, encircled by the 
other helices; it has been considered the pore formation do- 
main. Domain II consists of three anti-parallel [3-sheets har- 
ing similar topologies, packed around a hydrophobic ore. 
This domain represents the most divergent part in sequence 
and has been described as the specificity determining domain, 
since reciprocal hybrid genes between closely related toxins 
(CrylAa and CrylAc) resulted in hybrid toxins with altered 
specificity [11,12]. The three protruding loops in the apex of 
domain II were suggested to be involved in receptor binding 
in Cryl and Cry3 toxins. Mutations located in these loops 
demonstrated that some residues are essential for binding to 
membranes of different lepidopteran or coleopteran insects 
[13--16]. Domain III is a [~-sandwich of two anti-parallel [3- 
sheets. It has been proposed that it stabilizes the toxin by 
protection from proteolysis [7,17]. However, recent reports 
suggest hat it may be involved in other processes uch as 
receptor binding [18,19] and regulation of the pore formation 
activity [20]. 
Receptor binding is a key factor in specificity. Specific bind- 
ing involves two steps, one that is reversible and the other 
irreversible. Recent data suggest hat toxicity correlates with 
irreversible binding [2l]. Irreversible binding might be related 
to the toxin insertion into the membrane but could also reflect 
a tighter interaction of the toxin with the receptor. Mutations 
in domains I and II have suggested the participation of some 
residues in irreversible binding [14,20,22,23]. 
Numerous individual domains from modular proteins have 
been isolated by either limited proteolysis or gene manipula- 
tion. Viewed in this light, the ability to create an isolated 
domain may facilitate its functional analysis. Domain I ex- 
pressed independently [24,25] or isolated helix c~-5 peptides 
[26,27] retain their ability to form cation channels in planar 
lipid bfiayers when assayed at high concentrations. There have 
been no reports of domain II or III isolation and expression. 
In this work we present he isolation and characterization f a 
CrylAb isolated fragment containing domains I1 and III. 
2. Materials and methods 
2.1. Bacterial strains and plasmids 
Escherichia coli strain JM101 (supE thi-lD (lac-proAB) F' (traD36 
proAB+ laclq IacZDM15)) was used as host for electroporation [28]. 
E. coli strain BL21 (hsdS gal (lcIts857 indl Sam7 nin5 IacUV5-T7 gene 
1)), was used for the expression of the cloned domains. Plasmid 
pUC18 [29] was used for DNA cloning and sequencing and for ex- 
pression of the protein. 
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2.2. Construction of the N-terminal deletions of CrylAb 
The fragments for domain II or domains II-III of the crylAb gene 
from B. thuringiensis ubsp, berliner were obtained by PCR using 
plasmid pTP650 [30] as a template. Primers were designed to isolate 
domain II or domains II-III from the erylAb gene, as a translational 
fusion at codon 17 of the lacZ coding region in pUC18. Primer A1 (5' 
CGG TAC CCG GGG ATC CTC TAG AGT CGA CAA GAG 
AAA TTT ATA CAA AC 3') contains a BamHI restriction site at 
the 5' end. Primers B1 (5' CAG TGC CAA GCT TGC TTT ACT 
GCA GAC TAC GAT GTA TCC AAG AGA A 3') and C1 (5' AGT 
GCC AAG CTT AGT GAT GGT GAT GGT GAT GAA CTA AAT 
TGG ATA CTT GAT C 3') contain a HindIII restriction site. Primer 
C1 adds six His codons at the C-terminal end to allow purification of 
the resultant proteins with the aid of Ni affinity columns. PCR reac- 
tions with primers AI and B1 afforded domain II (aa 264-459). Pri- 
mers A1 and C1 were used for domains II-III construction (aa 264-- 
648). PCR reactions were performed as follows (30 cycles): 92°C, 
1 min; 55°C, 1 min and 72°C, 3 rain, in a RoboCycler (Stratagene). 
For cloning the domain II codifying region, the PCR fragment was 
cut with BamHI and HindIII restriction enzymes and cloned into 
pUC18 plasmid. The resultant construction is called pDomII. For 
domain II-III cloning, the PCR fragment was digested with HindIII 
and cloned in the same vector. The correct orientation was selected by 
restriction analysis. The resultant construction is called pDomII III- 
H6 and the corresponding toxin product domII-III-H6. Both con- 
structions were completely sequenced by the Sequenase dideoxy 
DNA sequencing r'nethod (US Biochemicals). 
2.3. Purification of CrylAb toxin and CrylAb protein fragments 
The purification of the CrylAb protoxin and the generation of the 
toxic trypsin resistant fragment were performed as described by H6fte 
et al. [31]. The toxin was further purified as described by Hofmann et 
al. [321. 
DomlI-III-H6 was expressed in BL21 E. coli cells. Purification of 
the protein was carried out by Ni-NTA-agarose affinity chromatog- 
raphy [33]. Briefly, an overnight culture of pDomII-III-H6 trans- 
formed cells was grown at 37°C in LB medium (200 lag m1-1 ampi- 
cillin). This culture was used to inoculate 100 ml LB medium (1:100). 
The cells were grown to an OD of 0.5-0.6 (600 nm), and induced with 
1 mM isopropyl thiogalactoside (IPTG). After 3 h of growth cells 
were centrifuged and suspended in 3 ml of buffer A (50 mM Na2SO4, 
300 mM NaC1, pH 8). The pellet was sonicated on ice (1 rain bursts, 
two times), centrifuged (10 min at 12000×g) and 0.5 ml of a 50% 
slurry Ni-NTA resin (Qiagen, Chatsworth, CA), equilibrated in buffer 
A, was added to the supernatant and stirred for 60 min (4°C). The 
resin containing the protein was poured into a 1 cm diameter column, 
and washed with buffer A, until the OD (280 nm) of the flow through 
was less than 0.01. Then, the column was washed with buffer B (50 
mM Na~PO4, 300 mM NaC1, 10% glycerol, pH 6). Non-specifically 
bound proteins were washed with 3 ml fractions of buffer B contain- 
ing 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 mM imidazole. Finally, 
specifically bound protein was eluted with 3 ml of buffer B containing 
200 mM imidazole. 
2.4. SDS-PAGE and Western blotting 
Proteins were separated by SDS-10% (w/v) PAGE as described by 
Laemmli [34]. Western blot analysis was performed as described [35], 
using a poly-CrylAb antiserum raised against CrylAb toxin 
(1:50000) [30], followed by incubation with a secondary goat anti- 
rabbit IgG antibody conjugated with alkaline phosphatase (I :2500). 
2.5. In vitro binding of CrylAb toxin and domain 11 I l l  fragment on 
tissue sections 
Histological sections of Manduca sexta or T. ni last instar midgut 
tissue were prepared as previously described [36]. The in vitro binding 
assays were performed using 20 lag ml 1 of CrylAb toxin or domlI 
III-H6 protein fragment, detected with the polyclonal anti-CrylAb 
solution, 1 mg m1-1 and peroxidase-conjugated goat anti-rabbit (Sig- 
ma). Sections were stained with the peroxidase substrate as described 
[36]. CrylAb toxin or domlI-III-H6, primary antibodies, enzyme con- 
jugated and secondary antibodies were sequentially omitted to exclude 
false positive results from tissue binding analysis. 
2.6. Protein ligand blot analysis 
Brush border membrane vesicles (BBMV) from T. ni or M. sexta 
fourth instar larvae were prepared as described by Wolfersberger tal. 
H. Flores et al./FEBS Letters 414 (1997) 313-318 
[37]. Protein blot analysis of BBMV preparations was done as de- 
scribed [38]. 20 lag of BBMV protein was separated by 9% SDS- 
PAGE and electrotransferred to nitrocellulose membranes. After re- 
naturation and blocking, blots were incubated for 3 h with 0.5 lag 
m1-1 of biotinylated CrylAb toxin or biotinylated omII-III-H6 in 
washing buffer (0.5% Tween 20 in TBS) at room temperature. Un- 
bound toxin was removed by washing three times for 10 min in wash- 
ing buffer and bound toxin was identified by streptavidin-peroxidase 
conjugate (1:1000 dilution) for 1 h and visualized using luminol (ECL, 
Amersham) as described by the manufacturers. 
2. Z Binding assays on isolated brush border membrane vesicles' 
Binding of biotinylated toxins to BBMV was performed as previ- 
ously described [38]. 20 lag of BBMV protein was incubated with 10 
nM biotinylated CrylAb toxin or biotinylated omII-III-H6 for 1 h 
in the presence or absence of 100-fold unlabeled CrylAb toxin. Un- 
bound toxin was then washed and proteins were electrophoresed on
PAGE, and transferred onto nitrocellulose membranes. The biotiny- 
lated proteins which were isolated with the vesicles were visualized by 
incubating with streptavidin-peroxidase conjugate (1:4000 dilution) 
and luminol as above. 
3. Results and discussion 
3.1. Expression o f  domain I I - I I I -H6 in E. coli 
The three domains of Cry3A and Cry lAa  toxins are rather 
closely packed together and the interfaces between domains 
are highly conserved [7,10]. The largest number  of interdo- 
main contacts are between domains I and II. Based on the 
sequence al ignment of Cry proteins in combinat ion with in- 
spection of the structure of Cry lAa  toxin (Fig. 1), we selected 
zones of the cry lAb gene to place the boundaries for domain 
II and domain I I - I I I  f ragment expression. 
The corresponding Cry lAb  domain II (24.3 kDa) and do- 
main I I - I I I  (45.3 kDa) coding fragments were cloned by PCR 
amplification. These constructions were expressed in E. coli 
BL21. The product of pDomI I  I I I -H6 construction (domI I -  
I I I-H6) is expressed in very low yields (Fig. 2). In contrast, the 
isolated domain II was not detected. These data may indicate 
that interactions between domains are necessary to stabilize 
the structure of domain II. Also, it has been suggested that 
some regions within domain II I  are important  determinants 
for proteolysis protection. Wabico and Yasuda [17] have re- 
ported the introduction of termination codons in the cry lAb 
gene. Mutat ions encoding 606 aa or more were toxic, whereas 
those encoding 605 aa or less were unstable, suggesting that 
some residues of domain III are important  for the structural 
integrity of the molecule. 
3.2. Binding o f  dom-I I  I I I -H6 analysis to midgut tissue 
sections 
Cry lAb  toxin and doml I  I I I -H6 were used for in vitro 
binding analysis to midgut tissue sections of M. sexta and 
T. ni larvae. The tissue sections were incubated with the native 
toxin or with doml I - I I I -H6,  and bound proteins were de- 
tected by ant ibody incubation as described in Section 2. We 
found that both proteins bound evenly along the top of the 
microvilli of the midgut epithelium of M. sexta larvae (Fig. 
3A,B) and also to the complete microvilli membrane of T. ni 
midgut cells (Fig. 3D,E). These data indicate that domains I I -  
III expressed independently retain binding functionality in the 
absence of domain I, since doml I - l l I -H6  is able to interact 
with the tissue section microvilli similar to the complete toxin. 
No binding to other structures uch as Malpighian tubules, 
basement membrane or muscle cells was observed. 
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Fig. 1. Crystal structure of CrylAa toxin (modified from Grochulski et al. [10]). A: Schematic ribbon representation f the three domain tdo- 
main I-Ill) organization of the toxin. The positions of the boundaries for domain II (Thr-'64-Se& 59) and domain 11 Ill (Thr'-'~;~-Asn ~i5~) are indi- 
cated• B: Representation of isolated omain II-III. 
3.3. Protein blots 
The 210 kDa cadherin-like glycoprotein from M. sexta has 
been identified as CrylAb toxin binding protein [39,40] and 
an aminopeptidase N from M. sexta, Heliothis virescens. Plu- 
tella xylostella and Lymantria di3par as the CrylAc toxin 
binding protein [4145]. However, it has been demonstrated 
that CrylAb also binds with high affinity to the purified 120 
kDa aminopeptidase N CrylAc toxin binding protein purified 
from M. sexta [46]. Some authors have shown that also in 
ligand blot experiments performed with BBMV from M. sexta 
the CrylAb toxin binds to both 120 and 210 kDa proteins 
[14,23]. 
In order to investigate the specific proteins, responsible for 
the interaction between domlI III-H6 and the BBMV of both 
insects, we analyzed the toxin binding protein complexes em- 
ploying the ligand blot technique. Membrane vesicle proteins 
from T. ni and M. sexta larvae were resolved by SDS-PAGE, 
transferred to nitrocellulose membranes and incubated with 
biotinylated CrylAb toxin or domII-I I I-H6. After washing 
the unbound toxin, the biotinylated proteins were visualized 
by incubation with streptavidin-peroxidase conjugate. The re- 
sults indicate that both proteins bound to a 150 kDa protein 
in T. ni membranes (Fig. 4A, lanes 1 and 3) and that this 
interaction is specific since binding of biotinylated omain 
lI III-H6 can be eliminated by incubation of the biotinylated 
protein fragment with the BBMV in the presence of a 100-fold 
excess of unlabeled CrylAb toxin (Fig. 4A, lane 2). In M. 
sexta membranes the CrylAb toxin binds to 120 kDa and 
210 kDa proteins (Fig. 4B, lane 1) while domII- I I I -H6 only 
binds to a 210 kDa protein (Fig. 4B, lane 3). We do not have 
a definitive xplanation for the lack of binding to the 120 kDa 
protein by domII-I I I-H6, a possibility is that domain I may 
be involved in the interaction with the 120 kDa protein or 
that the structure of domII- l I I -H6 could be altered affecting 
this interaction. 
3.4. Homologous competition binding analysis 
To study the binding characteristics of domII III-H6 with 
native membrane preparations, binding experiments with bio- 
tinylated omII- I I I -H6 to freshly isolated T. ni BBMV were 
performed. BBMV were incubated with biotinylated CrylAb 
toxin or domII- I I I -H6 in the presence or absence of a 100- 
fold excess of CrylAb native toxin. Subsequently, the un- 
bound toxin was washed off and the BBMV containing the 
bound toxin were analyzed by SDS-PAGE. Alter electropho- 
resis and blotting on nitrocellulose membranes, the biotiny- 
lated crystal proteins were visualized by incubation with the 
streptavidin-peroxidase conjugate. Fig. 5 shows the binding of 
biotinylated CrylAb toxin (Fig. 5, lane I) and no binding of 







Fig. 2. Western blot analysis of domll III-H6 expression in E2 coli 
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Fig. 3. Immunolocalization f proteins bound to midgut tissue sections of M. sexta (A-C) and T. ni (D-F) larvae. Midgut sections were incu- 
bated with CrylAb toxin (A, D) or domlI-III-H6 (B, E) solutions. DomlI-III-H6 and CrylAb toxin bound to the top of the M. sexta apical 
microvilli (A, B). In contrast, they bound to the whole microvillus membrane of T. ni tissue sections (D, E). None of them bound to other or- 
gans such as trachea or Malpighian tubules. Negative control with no ICP incubation (C, F) showed no staining. BM, basement membrane 
and connective tissue; L, lumen; AMV, apical microvilli. Bar=20 I.tm. 
has been proposed that residues F371 and G374 from domain 
II of Cry lAb play an important role in the irreversible inter- 
action of the toxin with its receptor, since mutants affected in 
these residues lost toxicity and showed reduced irreversible 
binding without affecting initial binding [23]. However, mu- 
tants in these residues have not lost total irreversible binding, 
suggesting the existence of other important contacts with the 
receptor or the membrane in other parts of the toxin molecule 
that could also participate in the irreversible binding. Our 
data indicate that the interaction of doml I - I I I -H6 with the 
BBMV is quite reversible; this could be due to the absence of 
domain I which might be necessary to obtain irreversible 
binding to the membrane due to membrane insertion. How- 
ever, we cannot exclude the possibility that doml I - I I I -H6 
could be altered in some way that disrupts its irreversible 
binding. The determination of the three-dimensional structure 
of doml I - I I I -H6 could be a way to analyze if it has a different 
structure. Also, a future determination of on- and off-rate 
binding constants to native purified receptor would determine 
if the binding of doml I - I I I -H6 is the same as the whole toxin. 
Several proteins are organized as discrete modules which 
may have different functions. It has been proposed that the 
different domains of modular proteins could have evolved 
independently and that domain swapping may contribute to 
the versatility of protein function [47,48]. The Cry proteins are 
a family that have biocidal activities against very different 
targets. These proteins are modular in structure. It has been 
reported that the vitelline membrane outer layer protein I 
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Fig. 4. Ligand blotting assay on T. ni and M. sexta BBMV. BBMV 
proteins were loaded onto a SDS-PAGE and blotted to a nitrocellu- 
lose membrane. T. ni (A) or M. sexta (B) BBMV were incubated 
with biotinylated omlI-llI-H6 (lanes A1, B3) and biotinylated 
CrylAb toxin (lanes A3, 131) and bound toxins were detected by 
means of streptavidin-peroxidase conjugate as described in Section 
2. Lane A2 showed the competition of the biotinylated domlI III- 
H6 fragment with a 100-fold excess of unlabeled CrylAb toxin. 
Lane B2 showed the competition of the biotinylated CrylAb toxin 
with a 100-fold excess of unlabeled CrylAb toxin. 
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Fig. 5. Homologous competition binding assays on T. ni BBMV. Bi- 
otinylated CrylAb toxin (lanes 1 and 2) and biotinylated omII- 
III-H6 (lanes 4 and 5) were incubated with BBMV in the absence 
(lanes 1 and 4) or the presence of a 100-fold excess of CrylAb unla- 
beled toxin (lanes 2 and 5). After 1 h incubation, unbound toxins 
were removed and vesicles containing bound toxins were loaded 
onto a SDS-PAGE and blotted to a nitrocellulose membrane. La- 
beled proteins were visualized by means of streptavidin-peroxidase 
conjugate. Lane 3, biotinylated omll III-H6 directly loaded on the 
SDS-PAGE 
(VMO-I) and domain II from Cry have similar three-dimen- 
sional structures and it has been proposed that the [3-prism 
fold may be a structural domain associated with carbohydrate 
binding functionality [49]. Both proteins may have a carbohy- 
drate binding site, since binding of Cry lAc toxin to its recep- 
tor is inhibited by N-acetylgalactosamine [50] and the VMO-I  
binds hexasaccharides of N-acetylglucosamine [51]. Unfortu- 
nately, the inability to express domain II in isolation did not 
allow us to test if this domain is the major contributor to 
specific binding. 
However, in this work, we present evidence that domains 
I I - I I I  expressed independently are able to interact with the 
membranes of lepidopteran insects in a rather similar way 
to the complete Cry lAb toxin, confirming that this part of 
the toxin is involved in binding interactions and that they 
could be separated as a discrete fragment that conserves at
least part of its functionality. 
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